NeuroNova-1

N/A

Report date: 2025/03/27 18:00:59

Base Information

Drug NameNeuroNova-1
Drug Alias NameNSC-CRAD-S PK7NNV-1CLD-101
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vectorBiologics > Oncolytic virusCell and gene therapy > Cell therapy > Stem cell therapy > Neural stem cell therapy
Mechanisms of ActionApoptosis stimulantsImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsGliomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNorthwestern University
China Registration ClassN/A

Develop Information

Active CompaniesCalidi Biotherapeutics IncNorthwestern University
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A